TCM

The computed 12-month bankruptcy probability of TCM is 2.7% (moderate). The annual accounts of TCM for financial year 2025 show a net loss of 54% of the equity at the start of that year. The 2025 annual accounts show equity of €4,921 and a net result of -€5,774. Equity is shrinking by about 21% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2028. Its solvency ranks better than 29% of 22,382 sector peers (NACE 47, financial year 2025). The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.